Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galenus Mannheim is a German pharmaceutical company and a subsidiary of the axicorp Group, specializing in the commercialization of generic drugs and value-added medicines. The company maintains a strong focus on respiratory health, offering a variety of inhalation therapies for conditions such as asthma and chronic obstructive pulmonary disease (COPD). In addition to its respiratory portfolio, Galenus Mannheim provides medications for pain management and oncology, targeting the German statutory health insurance market through competitive discount agreements. By leveraging the regulatory and logistical infrastructure of its parent company, Galenus Mannheim ensures a reliable supply of cost-effective therapeutic alternatives to the German healthcare sector. The company is headquartered in Friedrichsdorf and operates primarily within the German market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Galenus Mannheim.